Correlation Between IBio, Common and Calithera Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IBio, Common and Calithera Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IBio, Common and Calithera Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iBio, Common Stock and Calithera Biosciences, you can compare the effects of market volatilities on IBio, Common and Calithera Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IBio, Common with a short position of Calithera Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of IBio, Common and Calithera Biosciences.

Diversification Opportunities for IBio, Common and Calithera Biosciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between IBio, and Calithera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding iBio, Common Stock and Calithera Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Calithera Biosciences and IBio, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iBio, Common Stock are associated (or correlated) with Calithera Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Calithera Biosciences has no effect on the direction of IBio, Common i.e., IBio, Common and Calithera Biosciences go up and down completely randomly.

Pair Corralation between IBio, Common and Calithera Biosciences

If you would invest  238.00  in iBio, Common Stock on December 29, 2024 and sell it today you would earn a total of  174.00  from holding iBio, Common Stock or generate 73.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

iBio, Common Stock  vs.  Calithera Biosciences

 Performance 
       Timeline  
iBio, Common Stock 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in iBio, Common Stock are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, IBio, Common displayed solid returns over the last few months and may actually be approaching a breakup point.
Calithera Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Calithera Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Calithera Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

IBio, Common and Calithera Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IBio, Common and Calithera Biosciences

The main advantage of trading using opposite IBio, Common and Calithera Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IBio, Common position performs unexpectedly, Calithera Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calithera Biosciences will offset losses from the drop in Calithera Biosciences' long position.
The idea behind iBio, Common Stock and Calithera Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities